Compounds > epigallocatechin gallate
Page last updated: 2024-08-24

epigallocatechin gallate and Angiogenesis, Pathologic

epigallocatechin gallate has been researched along with Angiogenesis, Pathologic in 55 studies

Research

Studies (55)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (3.64)18.2507
2000's22 (40.00)29.6817
2010's29 (52.73)24.3611
2020's2 (3.64)2.80

Authors

AuthorsStudies
Chen, CY; Lan, SJ; Lan, YH; Lin, YJ; Sheu, MJ; Wang, CCN1
Han, DS; Lee, EO; Lee, HJ; Yeo, C1
Gallemit, PEM; Malaitad, T; Thongboonkerd, V; Yoodee, S1
Kroon, PA; Moyle, CWA; Needs, PW; Perez-Moral, N1
Chen, J; Chen, Z; Di, L; Hu, L; Huang, J; Li, J; Qiao, H; Wang, H; Wang, R; Yang, M1
Dupertuis, YM; Lecumberri, E; Miralbell, R; Pichard, C1
Feng, X; Feng, Y; Li, X; Liu, J; Tang, X; Zhou, K1
Fukusato, T; Kubota, S; Muraguchi, T; Sakamoto, Y; Terashita, N1
Hashimoto, O; Hiroshi, M; Inoue, K; Iwamoto, H; Nakamura, A; Nakamura, T; Sata, M; Torimura, T; Ueno, T1
Fukunaga, K; Maruyama, T; Murata, S; Nakayama, K; Nowatari, T; Nozaki, R; Ogawa, K; Ohkohchi, N; Sano, N; Tamura, T1
Chen, HY; Chiang, AN; Guo, BC; Lee, TS; Shyue, SK; Su, KH; Wei, J; Zhao, JF1
Lin, B; Liu, F; Liu, X; Shi, J; Tang, X; Zhang, W1
Bhatnagar, P; Gupta, KC; Kumar, P; Mishra, S; Shukla, Y; Singh, M1
Chen, YC; Gao, Y; Rankin, GO; Tu, Y1
Ahmed, RS; Chan, TH; Dou, QP; El-Banna, HA; El-Ghoneimy, AA; Farshi, P; Foldes, R; Liu, G; Renzetti, A; Saed, G; Soave, C; Yang, H1
Dhatwalia, SK; Dhawan, DK; Kumar, M1
Wang, H; Yang, CS1
McGeary, A; Penack, O; Rudloff, S; Westphal, S; Wilke, A1
Goodarzi, M; Malekzadeh, M; Masoudifar, A; Mirzaei, H; Rashidi, B1
Chan, TH; Chan, WK; Lam, WH; Lee, SC; Lee, TW; Wang, X; Wong, YC1
Cai, SR; He, YL; Wang, Z; Zhan, WH; Zhang, CH; Zhu, BH1
Hida, K; Hida, Y; Matsuda, K; Muraki, C; Ohga, N; Ohiro, Y; Shindoh, M; Totsuka, Y; Tsuchiya, K1
Baron, ED; Camouse, MM; Cooper, KD; Domingo, DS; Hsia, AH; Maes, D; Matsui, M; Ward, NL1
Asakawa, T; Kan, T; Oku, N; Piyaviriyakul, S; Shimizu, K; Siripong, P1
Shi, X; Xu, W; Yao, H; Zhang, Z1
Banik, NL; Karmakar, S; Mohan, N; Ray, SK1
Balacescu, L; Balacescu, O; Berindan-Neagoe, I; Braicu, C; Gherman, C; Irimie, F; Rus, M; Soritau, O; Tudoran, O; Virag, P1
Becker, CM; Birsner, AE; Chu, CY; D'Amato, RJ; Davis, TN; Kung, AL; Lui, WT; Wai Man, GC; Wang, CC; Xu, H1
Wu, H; Xiao, Y; Xin, Y; Zhao, J1
Banik, NL; Hossain, MM; Ray, SK1
Chan, TH; Cheng, JT; Chu, CY; Chu, KO; He, YX; Kwong, J; Lau, TS; Li, G; Man, GC; Qin, L; Wang, CC; Xu, H; Zhang, T1
Marsh, L; Shankar, S; Srivastava, RK1
Barañao, RI; Bastón, JI; Bilotas, MA; Meresman, GF; Olivares, CN; Ricci, AG; Singla, JJ1
He, L; Le, AD; Li, X; Shi, J; Tang, X; Zhang, E; Zhang, Q; Zhou, K1
Beatty, P; Brooks, MN; Elashoff, D; Elashoff, R; Go, VL; Heber, D; Sartippour, MR; Zhang, L1
Akizawa, T; Asai, T; Matsukawa, M; Oku, N; Uchida, T; Yamakawa, S1
Albini, A; Benelli, R; Fassina, G; Minghelli, S; Morini, M; Noonan, DM; Venè, R1
Chao, WT; Chen, YT; Lai, HC; Yang, VC1
Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW1
Band, MA; Guo, W; Liu, L; Meydani, M; Paulson, EK; Rodriguez, SK1
Adhami, VM; Mukhtar, H; Saleem, M; Siddiqui, IA1
Afaq, F; Ahmad, N; Khan, N; Mukhtar, H; Saleem, M1
Bayer, DK; Beltz, LA; Moss, AL; Simet, IM1
Blumberg, JB; Boucher, Y; Eisenberg, DM; Held, KD; Jain, RK; Kashiwagi, S; Lawenda, BD; Loeffler, JS; Niemierko, A; Silverstein, JR; Smith, DE; Xu, L1
Biggin, S; Caniato, R; Dell'Aica, I; Garbisa, S1
Cai, SR; He, YL; Li, ZR; Ma, JP; Peng, JS; Wang, Z; Zhan, WH; Zhang, CH; Zhu, BH1
Ganapathy, S; Shankar, S; Srivastava, RK1
Buxton, IL; Javed, MA; Law, WE; Rumjahn, SM; Wong, N1
Ganapathy, S; Hingorani, SR; Shankar, S; Srivastava, RK1
Adhami, VM; Asim, M; Hafeez, BB; Malik, A; Mukhtar, H; Sarfaraz, S; Siddiqui, IA1
Hsiao, TY; Kok, SH; Lin, SK; Liu, CM; Shun, CT; Wang, CC1
Cao, R; Cao, Y1
L'Allemain, G1
Albini, A; De Flora, S; Ferrari, N; Tosetti, F1
Ellis, LM; Jung, YD1

Reviews

12 review(s) available for epigallocatechin gallate and Angiogenesis, Pathologic

ArticleYear
Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
    Clinical nutrition (Edinburgh, Scotland), 2013, Volume: 32, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Cycle; Chemotherapy, Adjuvant; Humans; Neoplasms; Neovascularization, Pathologic; Polyphenols; Tea

2013
Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:11

    Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Artemisinins; Catechin; Cell Proliferation; Curcumin; Humans; Neoplasms; Neovascularization, Pathologic; Plant Extracts; Resveratrol; Stilbenes; Triterpenes

2016
Cancer Preventive Activities of Tea Catechins.
    Molecules (Basel, Switzerland), 2016, Dec-09, Volume: 21, Issue:12

    Topics: Animals; Apoptosis; Catechin; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Neoplasms; Neovascularization, Pathologic; Tea

2016
Green tea and its anti-angiogenesis effects.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 89

    Topics: Animals; Catechin; Humans; MicroRNAs; Neovascularization, Pathologic; Tea; Vascular Endothelial Growth Factors

2017
Dietary flavonoids as cancer prevention agents.
    Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews, 2011, Volume: 29, Issue:1

    Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Curcumin; Diet; Flavonoids; Food; Humans; Isothiocyanates; Neovascularization, Pathologic; Signal Transduction

2011
Beneficial effects of tea and its polyphenols against prostate cancer.
    Molecular nutrition & food research, 2006, Volume: 50, Issue:2

    Topics: Androgens; Animals; Apoptosis; Catechin; Cell Cycle; Clinical Trials as Topic; Fermentation; Flavonoids; Gene Expression; Humans; Male; Neoplasm Transplantation; Neovascularization, Pathologic; Phenols; Polyamines; Polyphenols; Prostate-Specific Antigen; Prostatic Neoplasms; Signal Transduction; Tea

2006
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
    Cancer research, 2006, Mar-01, Volume: 66, Issue:5

    Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Clinical Trials as Topic; ErbB Receptors; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; NF-kappa B; Protease Inhibitors; Receptor, IGF Type 1; Signal Transduction; Tea; Vascular Endothelial Growth Factor A

2006
Mechanisms of cancer prevention by green and black tea polyphenols.
    Anti-cancer agents in medicinal chemistry, 2006, Volume: 6, Issue:5

    Topics: Animals; Antioxidants; Apoptosis; Arachidonic Acid; Catechin; Cell Cycle; Cell Proliferation; fas Receptor; Flavonoids; Gene Expression; Humans; Lipid Peroxidation; Lipoproteins, LDL; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; NF-kappa B; Nitric Oxide; Oncogenes; Oxidation-Reduction; Phenols; Polyphenols; Proteasome Inhibitors; Reactive Oxygen Species; Receptors, Androgen; Receptors, Aryl Hydrocarbon; Receptors, Growth Factor; Tea; Telomere; Tetrahydrofolate Dehydrogenase

2006
Matrix proteases, green tea, and St. John's wort: biomedical research catches up with folk medicine.
    Clinica chimica acta; international journal of clinical chemistry, 2007, Volume: 381, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Bridged Bicyclo Compounds; Catechin; Humans; Hypericum; Matrix Metalloproteinases; Neovascularization, Pathologic; Phloroglucinol; Pulmonary Fibrosis; Tea; Terpenes

2007
Green tea polyphenols: biology and therapeutic implications in cancer.
    Frontiers in bioscience : a journal and virtual library, 2007, Sep-01, Volume: 12

    Topics: Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Cell Proliferation; Flavonoids; Gene Expression Regulation; Humans; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Phenols; Polyphenols; Signal Transduction; Tea

2007
Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:1

    Topics: Acetylcysteine; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Catechin; Flavonoids; Humans; Models, Biological; Neoplasms; Neovascularization, Pathologic; Protease Inhibitors; Receptors, Cytoplasmic and Nuclear

2002
Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
    International journal of experimental pathology, 2001, Volume: 82, Issue:6

    Topics: Angiogenesis Inhibitors; Anticarcinogenic Agents; Catechin; Humans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Phytotherapy; Plant Extracts; Tea

2001

Trials

1 trial(s) available for epigallocatechin gallate and Angiogenesis, Pathologic

ArticleYear
Anti-angiogenic effects of epigallocatechin-3-gallate in human skin.
    International journal of clinical and experimental pathology, 2010, Aug-05, Volume: 3, Issue:7

    Topics: Administration, Cutaneous; Adult; Angiogenesis Inhibitors; Catechin; Dosage Forms; Double-Blind Method; Erythema; Face; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Male; Middle Aged; Neovascularization, Pathologic; Skin; Telangiectasis; Vascular Endothelial Growth Factor A

2010

Other Studies

42 other study(ies) available for epigallocatechin gallate and Angiogenesis, Pathologic

ArticleYear
Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 120

    Topics: Angiogenesis Inhibitors; Catechin; Cell Movement; Cell Proliferation; Cells, Cultured; Endoglin; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Neoplasm Invasiveness; Neovascularization, Pathologic; Pyrroles; Signal Transduction; Smad1 Protein; Vascular Endothelial Growth Factor A

2019
Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.
    International journal of molecular sciences, 2020, Jan-09, Volume: 21, Issue:2

    Topics: Antigens, CD; Cadherins; Catechin; Cell Line, Tumor; Cell Survival; Down-Regulation; Humans; Male; Neoplasm Invasiveness; Neovascularization, Pathologic; Nuclear Proteins; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Twist-Related Protein 1

2020
Epigallocatechin-3-gallate plays more predominant roles than caffeine for inducing actin-crosslinking, ubiquitin/proteasome activity and glycolysis, and suppressing angiogenesis features of human endothelial cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 141

    Topics: Angiogenesis Inhibitors; Caffeine; Catechin; Cell Line, Tumor; Cell Proliferation; Coffee; Cross-Linking Reagents; Endothelial Cells; Endothelium, Vascular; Glycolysis; Humans; Matrix Metalloproteinase 2; Neovascularization, Pathologic; Proteasome Endopeptidase Complex; Tea; Ubiquitin; Ubiquitination

2021
Hydrophobic Interactions Drive Binding between Vascular Endothelial Growth Factor-A (VEGFA) and Polyphenolic Inhibitors.
    Molecules (Basel, Switzerland), 2019, Jul-31, Volume: 24, Issue:15

    Topics: Catechin; Cell Proliferation; Circular Dichroism; Flavonoids; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Neovascularization, Pathologic; Polyphenols; Protein Binding; Protein Structure, Secondary; Signal Transduction; Surface Plasmon Resonance; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2019
Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles.
    Nanomedicine : nanotechnology, biology, and medicine, 2019, Volume: 21

    Topics: Animals; Apoptosis; Catechin; Colonic Neoplasms; Fluorouracil; HT29 Cells; Humans; Mice; Nanoconjugates; Neovascularization, Pathologic; Wheat Germ Agglutinins; Xenograft Model Antitumor Assays

2019
Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression.
    Journal of nutrigenetics and nutrigenomics, 2013, Volume: 6, Issue:3

    Topics: Base Sequence; Catechin; Cell Line, Tumor; DNA Primers; Down-Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin-Like Growth Factor I; Lung Neoplasms; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction; Vascular Endothelial Growth Factor A

2013
Effects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis.
    Bioscience, biotechnology, and biochemistry, 2013, Volume: 77, Issue:9

    Topics: Animals; Antineoplastic Agents; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endostatins; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; RNA, Messenger; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2013
Methylated-(3'')-epigallocatechin gallate analog suppresses tumor growth in Huh7 hepatoma cells via inhibition of angiogenesis.
    Nutrition and cancer, 2014, Volume: 66, Issue:4

    Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; Mice; Mitogen-Activated Protein Kinase 1; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2014
(-)-Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer.
    Oncology reports, 2014, Volume: 31, Issue:2

    Topics: Animals; Anticarcinogenic Agents; Antioxidants; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Enzyme Activation; HCT116 Cells; Humans; Liver Neoplasms; Male; Mice; Mice, SCID; Neovascularization, Pathologic; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Vascular Endothelial Growth Factor Receptor-2

2014
Transient receptor potential vanilloid type 1 is vital for (-)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase.
    Molecular nutrition & food research, 2015, Volume: 59, Issue:4

    Topics: AMP-Activated Protein Kinases; Anilides; Animals; Calcium; Capsaicin; Catechin; Cell Movement; Cell Proliferation; Cell Survival; Cinnamates; Endothelial Cells; HEK293 Cells; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Signal Transduction; Tea; TRPV Cation Channels

2015
Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells.
    Oncology reports, 2015, Volume: 33, Issue:6

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Humans; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Neovascularization, Pathologic; Nicotine; Smoking; Tea; Xenograft Model Antitumor Assays

2015
PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Biflavonoids; Carcinoma, Ehrlich Tumor; Catechin; Cell Count; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Female; Flow Cytometry; Humans; Kinetics; Lactic Acid; Mice; Mitochondria; Nanoparticles; Neovascularization, Pathologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyphenols; Reactive Oxygen Species; Tea

2015
Theaflavin-3, 3'-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways.
    International journal of oncology, 2016, Volume: 48, Issue:1

    Topics: Biflavonoids; Carcinoma; Catechin; Cell Line, Tumor; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mitogen-Activated Protein Kinase Kinases; Neovascularization, Pathologic; Oncogene Protein v-akt; Ovarian Neoplasms; Proto-Oncogene Proteins c-myc; Receptor, Notch1; Signal Transduction; Vascular Endothelial Growth Factor A

2016
Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines.
    Journal of cellular biochemistry, 2016, Volume: 117, Issue:10

    Topics: Apoptosis; Blotting, Western; Catechin; Cell Movement; Cell Proliferation; Female; Fluorescent Antibody Technique; Humans; Leiomyoma; Neovascularization, Pathologic; Prodrugs; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tea; Tumor Cells, Cultured; Uterine Neoplasms

2016
The Green Tea Catechin Epigallocatechin Gallate Ameliorates Graft-versus-Host Disease.
    PloS one, 2017, Volume: 12, Issue:1

    Topics: Alkaloids; Allografts; Animals; Antioxidants; Benzodioxoles; Catechin; Disease Models, Animal; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neovascularization, Pathologic; Oxidative Stress; Piperidines; Polyunsaturated Alkamides; Quercetin; T-Lymphocytes, Regulatory; Tea

2017
Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
    Nutrition and cancer, 2008, Volume: 60, Issue:4

    Topics: Acetates; Androgens; Animals; Apoptosis; Biological Availability; Catechin; Cell Division; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Prodrugs; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Neoplasms; Tea; Transplantation, Heterologous

2008
[Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
    Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2009, Volume: 12, Issue:1

    Topics: Animals; Catechin; Cell Line, Tumor; Female; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2009
Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
    Cancer science, 2009, Volume: 100, Issue:10

    Topics: Animals; Anticarcinogenic Agents; Blotting, Western; Catechin; Cell Line, Tumor; Cell Movement; Down-Regulation; Endothelial Cells; Flavonoids; Flow Cytometry; Gene Expression; Humans; Matrix Metalloproteinase 9; Melanoma; Mice; Microvessels; Neovascularization, Pathologic; Phenols; Polyphenols; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stem Cells; Tea; Xenograft Model Antitumor Assays

2009
Anti-angiogenic activity and intracellular distribution of epigallocatechin-3-gallate analogs.
    Biological & pharmaceutical bulletin, 2011, Volume: 34, Issue:3

    Topics: Actins; Angiogenesis Inhibitors; Biological Transport; Camellia sinensis; Catechin; Cell Line; Cell Movement; Cell Proliferation; Cytoplasm; Endothelial Cells; Endothelium, Vascular; Humans; Mitochondria; Neovascularization, Pathologic; Plant Extracts

2011
SU5416 and EGCG work synergistically and inhibit angiogenic and survival factors and induce cell cycle arrest to promote apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-BE2 cells.
    Neurochemical research, 2011, Volume: 36, Issue:8

    Topics: Angiogenesis Inhibitors; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; E2F1 Transcription Factor; Humans; In Situ Nick-End Labeling; Indoles; Neovascularization, Pathologic; Neuroblastoma; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Retinoblastoma Protein; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2011
Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells.
    Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:3

    Topics: Angiogenesis Inhibitors; Apoptosis; Catechin; Cell Adhesion; Cell Movement; Cell Proliferation; Collagen; Drug Combinations; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Laminin; Neoplasm Invasiveness; Neovascularization, Pathologic; Proteoglycans; Signal Transduction; Transcription, Genetic; Uterine Cervical Neoplasms

2012
Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
    Fertility and sterility, 2011, Volume: 96, Issue:4

    Topics: Adult; Animals; Catechin; Cells, Cultured; Endometriosis; Female; Gene Expression Regulation; Humans; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Random Allocation; Signal Transduction; Tea; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-2

2011
Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts.
    Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Catechin; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2012
Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells.
    Experimental cell research, 2012, Aug-01, Volume: 318, Issue:13

    Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Caspases; Catechin; Cell Differentiation; Cell Line, Tumor; Cell Movement; Gene Knockdown Techniques; Humans; Inhibitor of Apoptosis Proteins; Neovascularization, Pathologic; Neuroblastoma; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Survivin

2012
Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
    Angiogenesis, 2013, Volume: 16, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biological Availability; Catechin; Endometriosis; Endometrium; Female; Mice; Neovascularization, Pathologic; Ovarian Follicle; Oxidation-Reduction; Prodrugs; Tea

2013
EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin.
    Molecular and cellular biochemistry, 2013, Volume: 372, Issue:1-2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Catechin; Cell Line, Tumor; Cell Proliferation; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Neuropilins; Pancreas; Pancreatic Neoplasms; Proliferating Cell Nuclear Antigen; Tumor Burden; Xenograft Model Antitumor Assays

2013
Natural therapies assessment for the treatment of endometriosis.
    Human reproduction (Oxford, England), 2013, Volume: 28, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Apoptosis; Catechin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endometriosis; Endometrium; Female; Humans; Injections, Intraperitoneal; Intestinal Diseases; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Random Allocation; Resveratrol; Stilbenes

2013
(-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
    Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Gene Expression; Human papillomavirus 16; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-8; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Oncogene Proteins; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Repressor Proteins; Signal Transduction; Transfection; Vascular Endothelial Growth Factor A

2013
Inhibition of fibroblast growth factors by green tea.
    International journal of oncology, 2002, Volume: 21, Issue:3

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Breast Neoplasms; Catechin; Cells, Cultured; Endothelium, Vascular; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Humans; Neovascularization, Pathologic; Plant Extracts; RNA, Messenger; Tea

2002
(-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.
    Cancer letters, 2004, Jul-08, Volume: 210, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Catechin; Cell Division; Cell Movement; Colonic Neoplasms; Endothelium, Vascular; Humans; Matrix Metalloproteinase 14; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Methylcholanthrene; Mice; Neovascularization, Pathologic; Sarcoma, Experimental; Tumor Cells, Cultured; Umbilical Veins; Urokinase-Type Plasminogen Activator

2004
Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Jul-15, Volume: 10, Issue:14

    Topics: Animals; Apoptosis; Capillaries; Catechin; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Nude; Neovascularization, Pathologic; NIH 3T3 Cells; Plant Preparations; Sarcoma, Kaposi; Tea; Vascular Neoplasms; Xenograft Model Antitumor Assays

2004
Effect of EGCG, a major component of green tea, on the expression of Ets-1, c-Fos, and c-Jun during angiogenesis in vitro.
    Cancer letters, 2004, Sep-30, Volume: 213, Issue:2

    Topics: Animals; Anticarcinogenic Agents; Aorta; Blotting, Western; Catechin; Cell Culture Techniques; Cell Division; Collagen; Culture Media; Down-Regulation; Endothelial Cells; Morphogenesis; Neovascularization, Pathologic; Proto-Oncogene Protein c-ets-1; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ets; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Transcription Factors; Umbilical Veins

2004
Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
    Oncology reports, 2005, Volume: 13, Issue:2

    Topics: Arginine; Ascorbic Acid; Bone Neoplasms; Catechin; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Lysine; Matrix Metalloproteinases; Neovascularization, Pathologic; Nutritional Physiological Phenomena; Osteosarcoma; Proline; Sarcoma, Ewing; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2005
Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.
    International journal of cancer, 2006, Apr-01, Volume: 118, Issue:7

    Topics: Catechin; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Neoplasms; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Signal Transduction; Tea; Umbilical Veins; Vascular Endothelial Growth Factor A

2006
Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodifying response on tumors in vivo? A pilot study with murine breast carcinoma.
    Journal of the Society for Integrative Oncology, 2007,Winter, Volume: 5, Issue:1

    Topics: Animals; Apoptosis; Breast Neoplasms; Carcinoma; Catechin; Cell Proliferation; Cells, Cultured; Combined Modality Therapy; Dietary Supplements; Female; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Pilot Projects; Radiation-Protective Agents; Vitamin E

2007
(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
    World journal of gastroenterology, 2007, Feb-28, Volume: 13, Issue:8

    Topics: Animals; Anticarcinogenic Agents; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endothelial Cells; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; STAT3 Transcription Factor; Stomach Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2007
Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase.
    British journal of cancer, 2007, Nov-19, Volume: 97, Issue:10

    Topics: Adenosine Triphosphate; Breast Neoplasms; Catechin; Cell Proliferation; Dose-Response Relationship, Drug; Ellagic Acid; Endothelial Cells; Humans; Neovascularization, Pathologic; Nucleoside-Diphosphate Kinase; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Tumor Cells, Cultured

2007
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer.
    Frontiers in bioscience : a journal and virtual library, 2008, Jan-01, Volume: 13

    Topics: Animals; Catechin; Cell Proliferation; Endothelium, Vascular; Extracellular Signal-Regulated MAP Kinases; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Pancreatic Neoplasms

2008
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Oncogene, 2008, Mar-27, Volume: 27, Issue:14

    Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Camellia sinensis; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Humans; Male; Neovascularization, Pathologic; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand

2008
Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis.
    Archives of otolaryngology--head & neck surgery, 2008, Volume: 134, Issue:5

    Topics: Antioxidants; Camellia sinensis; Catechin; Cell Hypoxia; Cells, Cultured; Cobalt; Fibroblasts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Nasal Polyps; Neovascularization, Pathologic; Plant Extracts; Vascular Endothelial Growth Factor A

2008
Angiogenesis inhibited by drinking tea.
    Nature, 1999, Apr-01, Volume: 398, Issue:6726

    Topics: Animals; Catechin; Cattle; Corneal Neovascularization; Drinking; Endothelium, Vascular; Mice; Neovascularization, Pathologic; Rats; Tea; Tumor Cells, Cultured

1999
[Multiple actions of EGCG, the main component of green tea].
    Bulletin du cancer, 1999, Volume: 86, Issue:9

    Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Division; Humans; Neovascularization, Pathologic; Tea

1999